JMCC Group

JMCC Group is the leading global provider of premium quality, sustainably grown, medical cannabis and psilocybin products and related services to customers around the world, including licensed producers, medical researchers, product developers, manufacturers and distributors. Our JMCC Source division combines Jamaica’s unique cannabis varieties and its optimal growing climate to produce the safest, most natural raw product possible to global quality standards for botanical medical ingredients. JMCC Scientific develops and produces cannabis-based treatments for a variety of conditions, including pain, anxiety and MS spasticity, under the guidance of leading medical specialists, who also guide JMCC’s participation in medical research initiatives worldwide. These include Project Twenty21 in the United Kingdom, Europe’s largest national medical cannabis registry, involving 20,000 patients by the end of 2021. JMCC Distribution gets our medical cannabis products and those of our distribution-services clients, to customers and research partners worldwide swiftly, securely and safely. Leveraging best practices, global scale, and long-standing relationships with leading transportation companies worldwide, JMCC Distribution encompasses our proprietary, state-of-the-art warehouse management system and GDP-compliant distribution centres in Jamaica, Australia and the EU to provide a seamless customer experience and eliminate supply interruptions for patients. Collaboration is key to building a successful, socially responsible medical cannabis industry. We work with a variety of partners, including the members of our Farmers’ Collective and other growers’ associations in Jamaica, medical research entities, cannabis industry groups, patient advocacy and public education organizations. Together, we’re striving to build a world where the benefits of medical cannabis are scientifically proven and available to all. Where Nature Meets Science.™